{{distinguish|Acridinium bromide|Aclidinium bromide}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 456493674
| IUPAC_name = 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1-methyl-1-azabicyclo[2.2.2]octan-1-ium bromide
| image = Clidinium bromide.svg
| width = 230
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|clidinium_bromide}}
| MedlinePlus = a601036
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = D
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability = Low
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion = [[Kidney|Renal]] and biliary
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7020-55-5
| CAS_supplemental = {{CAS|3485-62-9}}
| ATC_prefix = A03
| ATC_suffix = CA02
| ATC_supplemental = (combination with psycholeptics)
| PubChem = 2784
| IUPHAR_ligand = 366
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00771
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2682
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = BO76JF850N
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200950
<!--Chemical data-->
| C=22 | H=26 | N=1 | O=3| charge = + 
| molecular_weight = 352.447 g/mol
| smiles = O=C(OC2C1CC[N+](CC1)(C)C2)C(O)(c3ccccc3)c4ccccc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = HOOSGZJRQIVJSZ-UHFFFAOYSA-N
}}
'''Clidinium bromide''' ([[International Nonproprietary Name|INN]]) is an [[anticholinergic]] (specifically a [[muscarinic antagonist]]) [[drug]].<ref>{{cite web|url=http://www.drugs.com/international/clidinium-bromide.html|title=Clidinium bromide|publisher=Drugs.com|accessdate=August 24, 2013}}</ref> It may help symptoms of cramping and abdominal/stomach pain by decreasing [[gastric acid|stomach acid]], and slowing the intestines. It is commonly prescribed in combination with [[chlordiazepoxide]] (a benzodiazepine derivative) using the brand name [[Librax]].

== Uses ==
=== Peptic ulcer disease ===
Used in fixed combination with chlordiazepoxide as adjunctive therapy in the treatment of peptic ulcer disease; however, no conclusive data that antimuscarinics aid in the healing, decrease the rate of recurrence, or prevent complications of peptic ulcers.<ref>{{cite web|url=http://www.drugs.com/monograph/clidinium-bromide.html|title=Clidinium Bromide Monograph|publisher=Drugs.com|accessdate=August 24, 2013}}</ref>

With the advent of more effective therapies for the treatment of peptic ulcer disease, antimuscarinics have only limited usefulness in this condition.

=== GI motility disturbances ===
Used in fixed combination with chlordiazepoxide in the treatment of functional GI motility disturbances (e.g., irritable bowel syndrome).

Has limited efficacy in treatment of GI motility disturbance and should only be used if other measures (e.g., diet, sedation, counseling, amelioration of environmental factors) have been of little or no benefit.

=== Acute enterocolitis ===
Used in fixed combination with [[chlordiazepoxide]] in the treatment of acute [[enterocolitis]]. However, [[Muscarinic antagonist|antimuscarinics]] should be used with extreme caution in patients with diarrhea or [[ulcerative colitis]].

==Mechanism of action==
Clidinium inhibits [[muscarinic acetylcholine receptor]]s on [[Smooth muscle tissue|smooth muscle]]s, [[Exocrine gland|secretory gland]]s, and in the [[central nervous system]] to relax [[Smooth muscle tissue|smooth muscle]] and decrease [[Hepatobiliary system|biliary tract]] secretions.<ref name="jones and bartlett">{{cite book|title=2014 Nurses Drug Handbook|date=2014|publisher=Jones & Bartlett Learning|location=Burlington, MA|isbn=978-1-284-03115-7|pages=245-6|edition=13th}}</ref>

==References==
{{reflist}}

==External links==
*[http://www.rxlist.com/cgi/generic/librax.htm RxList.com - Librax]
*[http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601036.html MedlinePlus.Gov - Librax]


{{Muscarinic acetylcholine receptor modulators}}

[[Category:Muscarinic antagonists]]
[[Category:Quaternary ammonium compounds]]
[[Category:Bromides]]
[[Category:Acetates]]